260 related articles for article (PubMed ID: 16338252)
21. Bezafibrate and lovastatin decrease the oxidizability of low-density lipoproteins in heart transplant recipients with hyperlidemia.
Zambrana JL; López-Miranda J; Blanco A; Arizón JM; Jansen S; Paniagua JA; Jimenéz-Perepérez JA; Concha M; Pérez-Jiménez F
J Heart Lung Transplant; 1998 Dec; 17(12):1213-9. PubMed ID: 9883763
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients.
Bloomfield D; Carlson GL; Sapre A; Tribble D; McKenney JM; Littlejohn TW; Sisk CM; Mitchel Y; Pasternak RC
Am Heart J; 2009 Feb; 157(2):352-360.e2. PubMed ID: 19185645
[TBL] [Abstract][Full Text] [Related]
23. Effects of bezafibrate on HDL2/HDL3 ratio in postmenopausal hypertriglyceridemic women.
Ushiroyama T; Sakuma K; Nosaka S
J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):142-8. PubMed ID: 16891292
[TBL] [Abstract][Full Text] [Related]
24. Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease.
Su ZG; Zhang SZ; Hou YP; Zhang L; Huang DJ; Liao LC; Xiao CY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):780-5. PubMed ID: 12417924
[TBL] [Abstract][Full Text] [Related]
25. [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease].
Zhan Q; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Wang H
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):375-8. PubMed ID: 18510853
[TBL] [Abstract][Full Text] [Related]
26. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study.
Lindi V; Schwab U; Louheranta A; Vessby B; Hermansen K; Tapsell L; Riccardi G; Rivellese AA; Laakso M; Uusitupa MI;
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):88-95. PubMed ID: 17327141
[TBL] [Abstract][Full Text] [Related]
27. Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients.
Ying S; Sun YM; Liu XM; An CY; Gao YY
Biochem Biophys Res Commun; 2007 Nov; 363(2):395-8. PubMed ID: 17870053
[TBL] [Abstract][Full Text] [Related]
28. [Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia].
Vázquez-Chávez C; Salinas-Orozco S; Gómez-Díaz RA; Rosso-Juárez MM; Moreno-Vázquez K; Nissen-Torres T; Argüero-Sánchez R
Rev Invest Clin; 1998; 50(6):491-6. PubMed ID: 10070221
[TBL] [Abstract][Full Text] [Related]
29. [Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction].
Guan GD; Xu E; Wang XJ; Xu YH; Qiu SD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):519-22. PubMed ID: 17029199
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels of E-selectin in normolipemic and hyperlipemic arteriopathic patients after vasoactive and lipid-lowering treatment.
Ferlito S; Gallina M; Mugno F; Bisicchia A; Di Salvo MM
Minerva Cardioangiol; 2000 Mar; 48(3):47-52. PubMed ID: 10838833
[TBL] [Abstract][Full Text] [Related]
31. Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g).
Alrasadi K; Awan Z; Alwaili K; Ruel I; Hafiane A; Krimbou L; Genest J
Am J Cardiol; 2008 Nov; 102(10):1341-7. PubMed ID: 18993152
[TBL] [Abstract][Full Text] [Related]
32. Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.
St-Pierre J; Miller-Felix I; Paradis ME; Bergeron J; Lamarche B; Després JP; Gaudet D; Vohl MC
Mol Genet Metab; 2003 Jan; 78(1):31-6. PubMed ID: 12559845
[TBL] [Abstract][Full Text] [Related]
33. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
Bhavani AB; Sastry KB; Reddy NK; Padma T
Indian Heart J; 2005; 57(2):151-7. PubMed ID: 16013355
[TBL] [Abstract][Full Text] [Related]
34. Association of PPARalpha gene polymorphisms and lipid serum levels in a Brazilian elderly population.
Chen ES; Mazzotti DR; Furuya TK; Cendoroglo MS; Ramos LR; Araujo LQ; Burbano RR; Smith Mde A
Exp Mol Pathol; 2010 Feb; 88(1):197-201. PubMed ID: 19822141
[TBL] [Abstract][Full Text] [Related]
35. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
Kuryata OV; Yegorova YV
Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia.
Pasalić D; Sertić J; Kunović B; Milicević Z; Pasić A; Zrinski-Topić R; Ferencak G; Stavljenić-Rukavina A
Croat Med J; 2001 Oct; 42(5):517-22. PubMed ID: 11593500
[TBL] [Abstract][Full Text] [Related]
37. [A comparison of bezafibrate and lovastatin treatment at the usual doses in post-heart transplant hyperlipemia].
Zambrana García JL; López Miranda J; Anguita Sánchez M; Blanco Cerrada J; Vallés Belsúe F; Casares Mediavilla J; Muñoz Carvajal I; Jiménez Perepérez JA; Pérez Jiménez F
Rev Esp Cardiol; 1996 Dec; 49(12):892-8. PubMed ID: 9026840
[TBL] [Abstract][Full Text] [Related]
38. [Effect of polymorphism of human intestinal fatty acid binding protein gene on the therapeutic efficacy of fenofibrate].
Chang XT; Wang ZH; Du X; Dong MG; Hou LJ; Liu J; Wang J; Zhou JG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):230-3. PubMed ID: 16733910
[TBL] [Abstract][Full Text] [Related]
39. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population.
Yang LL; Hua Q; Liu RK; Yang Z
Arch Med Res; 2009 Feb; 40(2):89-96. PubMed ID: 19237017
[TBL] [Abstract][Full Text] [Related]
40. Statin use in a "real-world" clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial.
Koren MJ
Am J Med; 2005 Dec; 118 Suppl 12A():16-21. PubMed ID: 16356803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
